FDA approves first medical device for obesity treatment targeting brain-to-stomach signaling

The United States Food and Drug Administration (FDA) approved EnteroMedic’s VBLOC® vagal blocking therapy, delivered via the Maestro® System, which is the first medical device approved for obesity treatment that targets the nerve pathway between the brain and the stomach. The Obesity Society calls this a “a novel device that interrupts signals from the stomach to the brain that are believed to be involved with stomach emptying and feelings of fullness.”

from Fitness News — ScienceDaily http://ift.tt/1we6mIN
Read BellyTrim XP Review: http://ift.tt/1vIh8Jg

Advertisements